Holliston

Holliston biotechnology company Biostage Inc. saw its net losses for the year climb by $3.1 million to approximately $8 million as a result of ongoing wrongful death litigation.

As a small business owner, Erin Reardon Defoyd has forged her own path, leveraging powerful insights gleaned from more than a decade of corporate experience.

People are on the move at Country Bank, Spectrum Health Systems, Inc., RCAP Solutions, and more.

Biostage, Inc., a biotech company in Holliston working to bring throat implants to the market, hired its founder and former CEO David Green back to lead the company after roughly six years of absence, according to a Tuesday press release.

New England Cannabis Corp., Inc., a cannabis cultivator headquartered in Holliston, will be sold for $55 million to Canadian cannabis operator and retailer 4Front Ventures Corp., according to a Thursday press release from 4Front.

Harvard Bioscience, a life science equipment manufacturer based in Holliston, reported a net loss of $410,000 for the company’s second quarter financials in an earnings report released on Thursday.

Holliston biotechnology company Biostage Inc. reported it has $500,000 in operating cash on hand, enough to carry it into the third quarter.

Holliston biotechnology firm Harvard Bioscience continued its fourth quarter momentum with revenue up 14% in the first quarter of 2021 when compared to the first quarter of 2020.

Home prices continued to spike throughout Massachusetts in March, according to Peabody real estate data firm The Warren Group, with the median single-family sale price spiking 14.4% to $460,000, up from $402,000 in March 2020.

Holliston biotechnology company Biostage Inc. cut its yearly losses by $3.4 million through reductions in research & development and administrative expenses.